KHK6640
6640-003
Phase 1 small_molecule completed
Quick answer
KHK6640 for Alzheimer Disease is a Phase 1 program (small_molecule) at KYOWA KIRIN AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KYOWA KIRIN AUSTRALIA PTY LTD
- Indication
- Alzheimer Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed